| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7e87f29e0db9416800cab4f60f6c468 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4816 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 |
| filingDate |
2016-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c19bf0b686b33deacec7ca6d9f2a9d3e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23023af8ca77b2e83c951dfde545cd9c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2def5ddb16b1973266d3ac1aa21ffce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b043e529b4b1b6a43b814bcfb3a17b53 |
| publicationDate |
2018-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-2017013788-A |
| titleOfInvention |
STABILIZED PHARMACEUTICAL COMPOSITION. |
| abstract |
In the present invention there is provided a pharmaceutical composition comprising 5 - {[(3R) -1-acryloylpyrrolidin-3-yl] oxy} -6-ethyl-3 - ({4- [4- (4-methylpiperazin-1- il) piperidin-1-yl] phenyl} amin o) -pyrazine-2-carboxamide (herein referred to as "compound A") or a pharmaceutically acceptable salt thereof and stabilizes. The pharmaceutical composition comprises compound A or a pharmaceutically acceptable salt thereof and a pharmaceutical additive that has a difference in the value of water activity of 0.1 or more and is stabilized. |
| priorityDate |
2015-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |